Novartis vaccine plant takes top ISPE award; More pleas for illegit Botox sales;

@EricPFierce:  AstraZeneca thinks there is no place like home for new Zoladex plant. Story | Follow @EricPFierce

> Novartis' ($NVS) US Flu Cell Culture facility in Holly Springs, NC, was named the overall winner of the 2013 Facility of the Year Awards by the International Society for Pharmaceutical Engineering (ISPE). Report

> Hikma has rasied its forecast as its sales surge on strong demand for doxycycline, which the FDA says has been hard to get. Story

> Drugmaker Granules India has agreed to buy API maker Auctus Pharma. Story

> Belgian biotech company TiGenix is in advanced talks to sell its Dutch manufacturing facility. Story

> Capsugel will invest $20 million to expand the spray-drived dispersion manufacturing capacities of Bend Research, which it acquired last month. Report

And Finally... The feds have extracted guilty pleas from two more sales reps at Gallant Pharma International, based in Arlington, VA, for selling misbranded Botox and chemo drugs. Release

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.